BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

197 related articles for article (PubMed ID: 12126059)

  • 1. Use of fluorescently labeled caspase inhibitors as affinity labels to detect activated caspases.
    Grabarek J; Amstad P; Darzynkiewicz Z
    Hum Cell; 2002 Mar; 15(1):1-12. PubMed ID: 12126059
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In situ activation of caspases and serine proteases during apoptosis detected by affinity labeling their enzyme active centers with fluorochrome-tagged inhibitors.
    Grabarek J; Darzynkiewicz Z
    Exp Hematol; 2002 Sep; 30(9):982-9. PubMed ID: 12225789
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Detection of caspases activation by fluorochrome-labeled inhibitors: Multiparameter analysis by laser scanning cytometry.
    Smolewski P; Bedner E; Du L; Hsieh TC; Wu JM; Phelps DJ; Darzynkiewicz Z
    Cytometry; 2001 May; 44(1):73-82. PubMed ID: 11309811
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Fluorochrome-Labeled Inhibitors of Caspases: Expedient In Vitro and In Vivo Markers of Apoptotic Cells for Rapid Cytometric Analysis.
    Darzynkiewicz Z; Zhao H; Dorota Halicka H; Pozarowski P; Lee B
    Methods Mol Biol; 2017; 1644():61-73. PubMed ID: 28710753
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Activation of caspases measured in situ by binding of fluorochrome-labeled inhibitors of caspases (FLICA): correlation with DNA fragmentation.
    Bedner E; Smolewski P; Amstad P; Darzynkiewicz Z
    Exp Cell Res; 2000 Aug; 259(1):308-13. PubMed ID: 10942603
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Interactions of fluorochrome-labeled caspase inhibitors with apoptotic cells: a caution in data interpretation.
    Pozarowski P; Huang X; Halicka DH; Lee B; Johnson G; Darzynkiewicz Z
    Cytometry A; 2003 Sep; 55(1):50-60. PubMed ID: 12938188
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Fluorochrome-labeled inhibitors of caspases: convenient in vitro and in vivo markers of apoptotic cells for cytometric analysis.
    Darzynkiewicz Z; Pozarowski P; Lee BW; Johnson GL
    Methods Mol Biol; 2011; 682():103-14. PubMed ID: 21057924
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Assay of caspase activation in situ combined with probing plasma membrane integrity to detect three distinct stages of apoptosis.
    Smolewski P; Grabarek J; Halicka HD; Darzynkiewicz Z
    J Immunol Methods; 2002 Jul; 265(1-2):111-21. PubMed ID: 12072182
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Kinetics of HL-60 cell entry to apoptosis during treatment with TNF-alpha or camptothecin assayed by the stathmo-apoptosis method.
    Smolewski P; Grabarek J; Lee BW; Johnson GL; Darzynkiewicz Z
    Cytometry; 2002 Mar; 47(3):143-9. PubMed ID: 11891718
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Detection of caspase activation in situ by fluorochrome-labeled caspase inhibitors.
    Amstad PA; Yu G; Johnson GL; Lee BW; Dhawan S; Phelps DJ
    Biotechniques; 2001 Sep; 31(3):608-10, 612, 614, passim. PubMed ID: 11570504
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Labeling of apoptotic JURL-MK1 cells by fluorescent caspase-3 inhibitor FAM-DEVD-fmk occurs mainly at site(s) different from caspase-3 active site.
    Kuzelová K; Grebenová D; Hrkal Z
    Cytometry A; 2007 Aug; 71(8):605-11. PubMed ID: 17549763
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Detection of caspases activation in situ by fluorochrome-labeled inhibitors of caspases (FLICA).
    Darzynkiewicz Z; Bedner E; Smolewski P; Lee BW; Johnson GL
    Methods Mol Biol; 2002; 203():289-99. PubMed ID: 12073450
    [No Abstract]   [Full Text] [Related]  

  • 13. Stathmo-apoptosis: arresting apoptosis by fluorochrome-labeled inhibitor of caspases.
    Smolewski P; Grabarek J; Phelps DJ; Darzynkiewicz Z
    Int J Oncol; 2001 Oct; 19(4):657-63. PubMed ID: 11562738
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Activation of chymotrypsin-like serine protease(s) during apoptosis detected by affinity-labeling of the enzymatic center with fluoresceinated inhibitor.
    Grabarek J; Dragan M; Lee BW; Johnson GL; Darzynkiewicz Z
    Int J Oncol; 2002 Feb; 20(2):225-33. PubMed ID: 11788882
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Apoptotic cell death kinetics in vitro depend on the cell types and the inducers used.
    Wolbers F; Buijtenhuijs P; Haanen C; Vermes I
    Apoptosis; 2004 May; 9(3):385-92. PubMed ID: 15258471
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Activated caspase detection in living tissue combined with subsequent retrograde labeling, immunohistochemistry or in situ hybridization in whole-mounted lamprey brains.
    Hu J; Zhang G; Selzer ME
    J Neurosci Methods; 2013 Oct; 220(1):92-8. PubMed ID: 24025261
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Activation of caspases and serine proteases during apoptosis induced by onconase (Ranpirnase).
    Grabarek J; Ardelt B; Du L; Darzynkiewicz Z
    Exp Cell Res; 2002 Aug; 278(1):61-71. PubMed ID: 12126958
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Flow cytometry detection of caspase 3 activation in preapoptotic leukemic cells.
    Belloc F; Belaud-Rotureau MA; Lavignolle V; Bascans E; Braz-Pereira E; Durrieu F; Lacombe F
    Cytometry; 2000 Jun; 40(2):151-60. PubMed ID: 10805935
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Subcellular localization of caspase-3 activation correlates with changes in apoptotic morphology in MOLT-4 leukemia cells exposed to X-ray irradiation.
    Feng Y; Hu J; Xie D; Qin J; Zhong Y; Li X; Xiao W; Wu J; Tao D; Zhang M; Zhu Y; Song Y; Reed E; Li QQ; Gong J
    Int J Oncol; 2005 Sep; 27(3):699-704. PubMed ID: 16077919
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Detection of activated caspase-8 in injured spinal axons by using fluorochrome-labeled inhibitors of caspases (FLICA).
    Barreiro-Iglesias A; Shifman MI
    Methods Mol Biol; 2015; 1254():329-39. PubMed ID: 25431075
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.